• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为什么聚乙二醇400(PEG 400)共包封能提高神经生长因子(NGF)的稳定性以及从聚乳酸-羟基乙酸共聚物(PLGA)可生物降解微球中的释放?

Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

作者信息

Péan J M, Boury F, Venier-Julienne M C, Menei P, Proust J E, Benoit J P

机构信息

UPRES EA 2169, Faculté de Pharmacie, Angers, France.

出版信息

Pharm Res. 1999 Aug;16(8):1294-9. doi: 10.1023/a:1014818118224.

DOI:10.1023/a:1014818118224
PMID:10468034
Abstract

PURPOSE

The aim of this work was to understand the mechanism by which co-encapsulated PEG 400 improved the stability of NGF and allowed a continuous release from PLGA 37.5/25 microspheres.

METHODS

Microparticles were prepared according to the double emulsion method. PEG 400 was added with NGF in the internal aqueous phase (PEG/PLGA ratio 1/1 and 1.8/1). Its effect was investigated through interfacial tension studies. Protein stability was assessed by ELISA.

RESULTS

A novel application of PEG in protein stabilization during encapsulation was evidenced by adsorption kinetics studies. PEG 400 limited the penetration of NGF in the interfacial film of the primary emulsion. Consequently, it stabilized the NGF by reducing the contact with the organic phase. In addition, it avoided the NGF release profile to level off by limiting the irreversible NGF anchorage in the polymer layers. On the other hand, the amount of active NGF released in the early stages was increased. During microparticle preparation, NaCl could be added in the external aqueous phase to modify the structure of microparticles. This allowed to reduce the initial release rate without affecting the protein stability always encountered in the absence of PEG.

CONCLUSIONS

PEG 400 appeared of major interest to achieve a continuous delivery of NGF over seven weeks from biodegradable microparticles prepared by the double emulsion technique.

摘要

目的

本研究旨在了解共包封的聚乙二醇400(PEG 400)提高神经生长因子(NGF)稳定性并使NGF从聚乳酸-乙醇酸共聚物(PLGA 37.5/25)微球中持续释放的机制。

方法

采用复乳法制备微球。将PEG 400与NGF加入内水相中(PEG/PLGA比例为1/1和1.8/1)。通过界面张力研究考察其作用效果。采用酶联免疫吸附测定(ELISA)法评估蛋白质稳定性。

结果

吸附动力学研究证明了PEG在包封过程中对蛋白质稳定化的新应用。PEG 400限制了NGF渗透到初乳的界面膜中。因此,它通过减少与有机相的接触来稳定NGF。此外,它通过限制NGF在聚合物层中的不可逆锚定,避免了NGF释放曲线趋于平稳。另一方面,早期释放的活性NGF量增加。在微球制备过程中,可在外水相中加入氯化钠来改变微球结构。这能够降低初始释放速率,同时不影响在不存在PEG时始终能保持的蛋白质稳定性。

结论

对于通过复乳技术制备的可生物降解微球,PEG 400对于实现NGF持续七周的递送似乎至关重要。

相似文献

1
Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?为什么聚乙二醇400(PEG 400)共包封能提高神经生长因子(NGF)的稳定性以及从聚乳酸-羟基乙酸共聚物(PLGA)可生物降解微球中的释放?
Pharm Res. 1999 Aug;16(8):1294-9. doi: 10.1023/a:1014818118224.
2
NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.聚(D,L-丙交酯-共-乙交酯)微球释放神经生长因子。某些制剂参数对包封的神经生长因子稳定性的影响。
J Control Release. 1998 Dec 4;56(1-3):175-87. doi: 10.1016/s0168-3659(98)00086-8.
3
Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.聚乳酸-羟基乙酸共聚物微球中与聚乙二醇-聚(L-组氨酸)二嵌段共聚物复合的牛血清白蛋白的稳定性
J Control Release. 2005 Dec 5;109(1-3):86-100. doi: 10.1016/j.jconrel.2005.09.016. Epub 2005 Nov 2.
4
Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.基于热敏溶胶-凝胶转变的可生物降解三嵌段共聚物微球
Pharm Res. 2004 Feb;21(2):339-43. doi: 10.1023/b:pham.0000016248.30579.2f.
5
PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.替瑞利克斯的聚乳酸-羟基乙酸共聚物-聚乙二醇微球:聚合物类型对微球特性及替瑞利克斯体外释放的影响
Int J Pharm. 2003 Aug 11;261(1-2):69-80. doi: 10.1016/s0378-5173(03)00272-2.
6
Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.用低分子聚乙二醇对可生物降解的聚(苹果酸)和聚(乳酸-乙醇酸共聚物)微粒进行改性。
Drug Dev Ind Pharm. 2009 Apr;35(4):449-54. doi: 10.1080/03639040802438357.
7
Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.由可生物降解的LPLG-PEO-LPLG三嵌段共聚物制备的载促红细胞生成素微球:蛋白质稳定性及体外释放特性
J Control Release. 1998 Dec 4;56(1-3):105-15. doi: 10.1016/s0168-3659(98)00070-4.
8
Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency.聚乙二醇化腺病毒在聚乳酸-羟基乙酸共聚物微球中的微囊化以提高稳定性和基因转染效率。
Pharm Res. 2007 Dec;24(12):2263-9. doi: 10.1007/s11095-007-9441-y. Epub 2007 Oct 11.
9
Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres.用作乳化剂的聚乙二醇分子量对α-糜蛋白酶包封于聚乳酸-羟基乙酸共聚物微球中的稳定性的影响
J Pharm Pharmacol. 2005 Oct;57(10):1261-69. doi: 10.1211/jpp.57.10.0004.
10
Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates.聚(DL-丙交酯-乙交酯)与聚乙二醇衍生物的可生物降解微球的比较降解研究
J Microencapsul. 1999 Jan-Feb;16(1):83-94. doi: 10.1080/026520499289338.

引用本文的文献

1
Adsorption and Structuration of PEG Thin Films: Influence of the Substrate Chemistry.聚乙二醇薄膜的吸附与结构化:基底化学性质的影响
Polymers (Basel). 2024 Apr 29;16(9):1244. doi: 10.3390/polym16091244.
2
Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.重新定位,也要(纳米)重塑!纳米医学在抗击 SARS-CoV2 中的潜在作用。
J Control Release. 2021 Sep 10;337:258-284. doi: 10.1016/j.jconrel.2021.07.028. Epub 2021 Jul 20.
3
Interfacial tension effects on the properties of PLGA microparticles.

本文引用的文献

1
NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.聚(D,L-丙交酯-共-乙交酯)微球释放神经生长因子。某些制剂参数对包封的神经生长因子稳定性的影响。
J Control Release. 1998 Dec 4;56(1-3):175-87. doi: 10.1016/s0168-3659(98)00086-8.
2
Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.通过共包封添加剂提高微囊化破伤风类毒素的稳定性和释放动力学。
Pharm Res. 1998 Jul;15(7):1103-10. doi: 10.1023/a:1011998615267.
3
Stabilization of nerve growth factor in controlled release polymers and in tissue.
界面张力对 PLGA 微球性能的影响。
Colloids Surf B Biointerfaces. 2020 Dec;196:111300. doi: 10.1016/j.colsurfb.2020.111300. Epub 2020 Aug 23.
4
Injectable RANKL sustained release formulations to accelerate orthodontic tooth movement.可注射 RANKL 持续释放制剂加速正畸牙齿移动。
Eur J Orthod. 2020 Jun 23;42(3):317-325. doi: 10.1093/ejo/cjz027.
5
Growth Factor-Loaded Microparticles for Tissue Engineering: The Discrepancies of In Vitro Characterization Assays.用于组织工程的生长因子负载微粒:体外表征试验的差异
Tissue Eng Part C Methods. 2016 Feb;22(2):142-154. doi: 10.1089/ten.TEC.2015.0222. Epub 2015 Dec 14.
6
Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres.聚己内酯微球中胶质细胞源性神经营养因子的控释。
Drug Deliv Transl Res. 2014 Apr;4(2):159-70. doi: 10.1007/s13346-013-0189-0.
7
A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injury.作为周围神经损伤中神经元生长的神经治疗策略,对神经导管生物活性释放的综述。
Biomed Res Int. 2014;2014:132350. doi: 10.1155/2014/132350. Epub 2014 Jul 21.
8
Accelerating protein release from microparticles for regenerative medicine applications.加速微粒中蛋白质的释放,用于再生医学应用。
Mater Sci Eng C Mater Biol Appl. 2013 Jul 1;33(5):2578-83. doi: 10.1016/j.msec.2013.02.020. Epub 2013 Feb 21.
9
Assessment of insulin stability inside diblock copolymer PEG-PLA microspheres.双嵌段共聚物聚乙二醇-聚乳酸微球内胰岛素稳定性的评估
Sci Pharm. 2010 Jul-Sep;78(3):493-505. doi: 10.3797/scipharm.1002-01. Epub 2010 Jun 23.
10
Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF.利用聚合物化学调节可降解微球中神经营养因子的释放:BDNF 的释放。
Pharm Res. 2010 Jan;27(1):82-91. doi: 10.1007/s11095-009-0009-x. Epub 2009 Nov 17.
J Biomater Sci Polym Ed. 1996;8(2):103-17. doi: 10.1163/156856296x00183.
4
Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.用于在可生物降解微球中进行微囊化的重组人生长激素和干扰素-γ的稳定制剂。
Pharm Res. 1996 Oct;13(10):1464-75. doi: 10.1023/a:1016063109373.
5
Microencapsulated ciliary neurotrophic factor: physical properties and biological activities.
Exp Neurol. 1996 Apr;138(2):177-88. doi: 10.1006/exnr.1996.0056.
6
Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.通过溶剂蒸发法制备的聚乳酸纳米颗粒表面人血清白蛋白的吸附/解吸
J Biomed Mater Res. 1993 Aug;27(8):1019-28. doi: 10.1002/jbm.820270807.
7
In vitro effects of brain derived neurotrophic factor released from microspheres.微球释放的脑源性神经营养因子的体外效应
Neuroreport. 1994 Dec 20;5(18):2577-82. doi: 10.1097/00001756-199412000-00043.
8
Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin.含卵清蛋白的聚丙交酯(PLA)微球制备条件的优化。
Chem Pharm Bull (Tokyo). 1995 Sep;43(9):1569-73. doi: 10.1248/cpb.43.1569.
9
Effect of surfactants on the physical stability of recombinant human growth hormone.表面活性剂对重组人生长激素物理稳定性的影响。
J Pharm Sci. 1995 Jun;84(6):713-6. doi: 10.1002/jps.2600840609.
10
Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.参与p140trk(Trk)受体结合的神经生长因子的免疫决定因素。
J Neurosci Res. 1994 Mar 1;37(4):433-44. doi: 10.1002/jnr.490370402.